| Title: | Virus exposure and neurodegenerative disease risk across national biobanks |
| Journal: | Neuron |
| Published: | 19 Jan 2023 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/36669485/ |
| DOI: | https://doi.org/10.1016/j.neuron.2022.12.029 |
| Citations: | 139 (138 in last 2 years) as of 8 Aug 2024 |
Publication 7983
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
With recent findings connecting the Epstein-Barr virus to an increased risk of multiple sclerosis and growing concerns regarding the neurological impact of the coronavirus pandemic, we examined potential links between viral exposures and neurodegenerative disease risk. Using time series data from FinnGen for discovery and cross-sectional data from the UK Biobank for replication, we identified 45 viral exposures significantly associated with increased risk of neurodegenerative disease and replicated 22 of these associations. The largest effect association was between viral encephalitis exposure and Alzheimer's disease. Influenza with pneumonia was significantly associated with five of the six neurodegenerative diseases studied. We also replicated the Epstein-Barr/multiple sclerosis association. Some of these exposures were associated with an increased risk of neurodegeneration up to 15 years after infection. As vaccines are currently available for some of the associated viruses, vaccination may be a way to reduce some risk of neurodegenerative disease.10 Authors
- Kristin S Levine
- Hampton L Leonard
- Cornelis Blauwendraat
- Hirotaka Iwaki
- Nicholas Johnson
- Sara Bandres-Ciga
- Luigi Ferrucci
- Faraz Faghri
- Andrew B Singleton
- Mike A Nalls
1 Application
| Application ID | Title |
|---|---|
| 33601 | Dissecting the genetic architecture of neurodegenerative diseases |
Enabling scientific discoveries that improve human health